Skip to main content
DAEWOONG PHARMA logo

DAEWOONG PHARMA — Investor Relations & Filings

Ticker · 069620 ISIN · KR7069620003 KO Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2024-04-08 Capital/Financing Update
Country KR South Korea
Listing KO 069620

About DAEWOONG PHARMA

http://crm.daewoong.co.kr/eng/main

Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.

Recent filings

Filing Released Lang Actions
[발행조건확정]증권신고서(채무증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) specifically detailing the finalization of bond issuance terms (발행조건확정) for Daewoong Pharmaceutical. It outlines the interest rates and issuance yields for corporate bonds (16-1 and 16-2 series) following the determination of the base rate. This falls under the category of capital and financing updates, as it relates to the company's debt financing activities.
2024-04-08 Korean
[기재정정]증권신고서(채무증권)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) for debt securities (채무증권) filed by Daewoong Pharmaceutical. It explicitly states it is a 'Correction Report' (정정신고) regarding the issuance of corporate bonds, detailing changes in issuance amounts, interest rates, and underwriting terms following a demand forecast (수요예측). This falls under capital raising and financing activities, which is classified as 'CAP'.
2024-04-03 Korean
[발행조건확정]증권신고서(채무증권)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by Daewoong Pharmaceutical. It specifically details the 'Issuance Condition Confirmation' (발행조건확정) following a demand forecast (수요예측). This is a regulatory filing related to the issuance of corporate bonds (debt securities), which falls under the category of capital and financing updates.
2024-04-03 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service regarding their stake in Daewoong Pharmaceutical. This type of filing is a regulatory requirement in South Korea for entities that cross specific ownership thresholds in a publicly traded company. It falls under the category of 'Major Shareholding Notification' (MRQ) as it details the change in share ownership levels.
2024-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for Daewoong Pharmaceutical. It details the outcomes of agenda items such as financial statement approval, dividend declarations, and the election of directors and auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-28 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the change of the company's Representative Director (CEO). It lists the outgoing and incoming directors, the reason for the change (term expiration and new appointment), and the effective date. This falls directly under the category of board or management changes.
2024-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.